Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition for improving sleep comprising rare ginsenosides rg6 and f4
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A ginsenoside, a technology for improving sleep, applied in the field of biomedicine
Active Publication Date: 2021-05-07
SHAANXI GIANT BIOTECHNOLOGY CO LTD
View PDF5 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Ginsenosides Rg6 and F4 are produced by deglycosylation and dehydration of saponins Rg1 and Re of the triol group. At present, they are mainly used for the treatment of non-small cell lung cancer, antithrombotic, cerebral infarction, central retinal vein occlusion and other diseases. No report on sleep quality
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0058] This embodiment provides a sleep-improving capsule, which is prepared by mass from the following raw materials: 500g of stachyose and 100g of starch are mixed evenly, passed through a 60-80 mesh sieve, and used for later use. According to the corresponding proportion, ginsenoside Rg6 is added 25g, ginsenoside F4 25g, vitamin 1g, trace element iron 0.5g, mixed evenly, wet granulated with 80% ethanol, passed through a 20-80 mesh sieve, dried, granulated with a 20 mesh sieve, filled into capsules, packed in each capsule Amount 300mg.
Embodiment 2
[0060] This embodiment provides a sleep-improving tablet, which is prepared by mass from the following raw materials: 600g of stachyose and 100g of starch are mixed evenly, passed through a 60-80 mesh sieve, and used for later use. According to the corresponding proportion, ginsenoside Rg6 is added 28g, 14g of ginsenoside F4, 0.8g of vitamins, 0.5g of trace element iron, mixed evenly, wet granulated with 80% ethanol, passed through a 20-80 mesh sieve, dried, granulated with a 20 mesh sieve, pressed into tablets, each tablet weighs 800mg .
Embodiment 3
[0062] This example provides a sleep-improving tablet, which is prepared by mass from the following raw materials: 400g of stachyose and 100g of starch are mixed evenly, passed through a 60-80 mesh sieve, and used for later use. According to the corresponding proportion, ginsenoside Rg6 is added 20g, 30g of ginsenoside F4, 2g of vitamins, 0.3g of trace element iron, mixed evenly, wet granulated with 80% ethanol, passed through a 20-80 mesh sieve, dried, granulated with a 20 mesh sieve, pressed into tablets, each tablet weighs 800mg .
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a medicinal composition for improving sleep comprising rare ginsenosides Rg6 and F4. The pharmaceutical composition of the present invention comprises ginsenoside Rg6 and ginsenoside F4 in an effective amount for improving sleep as active ingredients, and a pharmaceutically acceptable carrier. In the pharmaceutical composition, the weight ratio of ginsenoside Rg6 to ginsenoside F4 is 1:1~3:1. According to the present invention, a pharmaceutical composition of rare ginsenosides comprising rare ginsenosides Rg6 and F4, synergistic and having a sleep-promoting effect can be provided.
Description
technical field [0001] The invention relates to the field of biomedicine, in particular to a rare ginsenoside Rg6 / F4 composition with sleep-promoting activity and synergistic effects. Background technique [0002] According to the statistics of the World Health Organization (WHO), 27% of people in the world have sleep problems, that is, at least 1 out of every 4 people "sleep well". According to the latest China sleep data report, from 2013 to 2018, the average sleep duration in China has dropped from 8.8 hours to 6.5 hours, waking up 1.8 times at night, and an average of 38.2% of Chinese people have sleep problems, which is higher than the global average. The value is 11.2% higher. Decreased sleep quality will not only affect the quality of work during the day, but also affect blood pressure, blood sugar, endocrine and immune functions, memory loss, dizziness, and drowsiness while driving. Long-term sleep can also cause negative emotions such as irritability, irritability...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
